HomeRVPHW • NASDAQ
add
Reviva Pharmaceuticals
Previous close
$0.14
Day range
$0.11 - $0.15
Year range
$0.075 - $1.72
Market cap
46.99M USD
Avg Volume
13.49K
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.13M | -28.28% |
Net income | -7.86M | 32.87% |
Net profit margin | — | — |
Earnings per share | -0.26 | 52.73% |
EBITDA | — | — |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.18M | -44.60% |
Total assets | 8.05M | -32.00% |
Total liabilities | 14.09M | 37.90% |
Total equity | -6.04M | — |
Shares outstanding | 29.82M | — |
Price to book | -0.69 | — |
Return on assets | -188.63% | — |
Return on capital | 593.59% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -7.86M | 32.87% |
Cash from operations | -8.48M | -59.41% |
Cash from investing | — | — |
Cash from financing | 2.68M | -48.58% |
Net change in cash | -5.80M | -5,474.17% |
Free cash flow | -4.68M | -1,005.75% |
About
Founded
2018
Headquarters
Website
Employees
15